TTNP

Titan Pharmaceuticals

Delisted

TTNP was delisted on the 1st of October, 2025.

17 hedge funds and large institutions have $787K invested in Titan Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
1
Closed
3
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
-$12K
Name Holding Trade Value Shares
Change
Shares
Change %
Truist Financial
1
Truist Financial
North Carolina
$519K
Renaissance Technologies
2
Renaissance Technologies
New York
$112K +$827 +50 +0.7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$68.1K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$53K
State Street
5
State Street
Massachusetts
$31.7K
UBS Group
6
UBS Group
Switzerland
$1.27K +$1.13K +68 +850%
TRCT
7
Tower Research Capital (TRC)
New York
$1K
LFA
8
Level Financial Advisors
New York
$819
Group One Trading
9
Group One Trading
Illinois
$273 +$32 +2 +13%
Bank of America
10
Bank of America
North Carolina
$170
Wells Fargo
11
Wells Fargo
California
$65
Fidelity Investments
12
Fidelity Investments
Massachusetts
$58 -$189 -13 -76%
BlackRock
13
BlackRock
New York
$50
GWSA
14
Global Wealth Strategies & Associates
Colorado
$33
Osaic Holdings
15
Osaic Holdings
Arizona
$29
Morgan Stanley
16
Morgan Stanley
New York
$23
WIM
17
Westside Investment Management
California
$3
NFSG
18
Newbridge Financial Services Group
Florida
$2 -$2
CSC
19
Caldwell Sutter Capital
California
$2 -$2
CIA
20
Cape Investment Advisory
Georgia
$1
VF
21
Virtu Financial
New York
-$16K -1,004 Closed
PNC Financial Services Group
22
PNC Financial Services Group
Pennsylvania
-$156 -10 Closed
IA
23
IFP Advisors
Florida
-$1K -1 Closed